Climate vaccine developer #ArkeaBio has raised $26.5 million in Series A funding, the company announced last week. ArkeaBio aims to fight climate change by vaccinating livestock.
A vaccine being developed by the company is designed to prevent animals from releasing methane emissions. Once vaccinated with the AkreaBio shot, an animal’s immune system is supposed to create antibodies that will target methane-producing microbes.
The Boston-based startup secured its first major investment in late 2022 from Breakthrough Energy Ventures, an investment fund founded by billionaire Bill Gates.
“Our vaccination-based approach allows for much-needed decarbonization of global meat and dairy products across multiple geographies, supporting greater sustainability in agriculture,” the company explains on its website.
https://x.com/newstart_2024/status/1796995139870605382
A vaccine being developed by the company is designed to prevent animals from releasing methane emissions. Once vaccinated with the AkreaBio shot, an animal’s immune system is supposed to create antibodies that will target methane-producing microbes.
The Boston-based startup secured its first major investment in late 2022 from Breakthrough Energy Ventures, an investment fund founded by billionaire Bill Gates.
“Our vaccination-based approach allows for much-needed decarbonization of global meat and dairy products across multiple geographies, supporting greater sustainability in agriculture,” the company explains on its website.
https://x.com/newstart_2024/status/1796995139870605382